Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer

PURPOSE: Genetic testing for breast cancer risk is evolving rapidly, with growing use of multiple-gene panels that can yield uncertain results. However, little is known about the context of such testing or its impact on treatment. METHODS: A population-based sample of patients with breast cancer dia...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Clin Oncol
Autores principales: Kurian, Allison W., Li, Yun, Hamilton, Ann S., Ward, Kevin C., Hawley, Sarah T., Morrow, Monica, McLeod, M. Chandler, Jagsi, Reshma, Katz, Steven J.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Clinical Oncology 2017
Materias:
ORIGINAL REPORTS
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5501363/
https://ncbi.nlm.nih.gov/pubmed/28402748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.71.6480
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares